1070 related articles for article (PubMed ID: 19487090)
21. Testosterone patch: new drug. Don't use to stimulate women's sexual desire.
Prescrire Int; 2007 Oct; 16(91):190-2. PubMed ID: 17926827
[TBL] [Abstract][Full Text] [Related]
22. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
23. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
[TBL] [Abstract][Full Text] [Related]
24. Should women receive androgen replacement therapy, and if so, how?
Davis SR
Clin Endocrinol (Oxf); 2010 Feb; 72(2):149-54. PubMed ID: 19650781
[TBL] [Abstract][Full Text] [Related]
25. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).
Leiblum SR; Koochaki PE; Rodenberg CA; Barton IP; Rosen RC
Menopause; 2006; 13(1):46-56. PubMed ID: 16607098
[TBL] [Abstract][Full Text] [Related]
26. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.
Nachtigall L; Casson P; Lucas J; Schofield V; Melson C; Simon JA
Gynecol Endocrinol; 2011 Jan; 27(1):39-48. PubMed ID: 21142609
[TBL] [Abstract][Full Text] [Related]
27. Androgen and menopause.
Somboonporn W
Curr Opin Obstet Gynecol; 2006 Aug; 18(4):427-32. PubMed ID: 16794424
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage G; Eden JA; Manga RZ
Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
[TBL] [Abstract][Full Text] [Related]
29. Patient scenario: a 53-year-old woman with hypoactive sexual desire disorder.
Palacios S; Graziottin A
Maturitas; 2009 Jun; 63(2):164-8. PubMed ID: 19487091
[TBL] [Abstract][Full Text] [Related]
30. Androgen insufficiency in women.
Braunstein GD
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S109-17. PubMed ID: 16631401
[TBL] [Abstract][Full Text] [Related]
31. Opportunities for intervention in HSDD.
Simon JA
J Fam Pract; 2009 Jul; 58(7 Suppl Hypoactive):S26-30. PubMed ID: 19825316
[TBL] [Abstract][Full Text] [Related]
32. Testosterone supplementation for hypoactive sexual desire disorder in women.
Woodis CB; McLendon AN; Muzyk AJ
Pharmacotherapy; 2012 Jan; 32(1):38-53. PubMed ID: 22392827
[TBL] [Abstract][Full Text] [Related]
33. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
Goldstat R; Briganti E; Tran J; Wolfe R; Davis SR
Menopause; 2003; 10(5):390-8. PubMed ID: 14501599
[TBL] [Abstract][Full Text] [Related]
34. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder.
DeRogatis LR; Graziottin A; Bitzer J; Schmitt S; Koochaki PE; Rodenberg C
J Sex Med; 2009 Jan; 6(1):175-83. PubMed ID: 19170847
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.
Bitzer J; Kenemans P; Mueck AO;
Maturitas; 2008 Mar; 59(3):209-18. PubMed ID: 18343056
[TBL] [Abstract][Full Text] [Related]
36. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo.
Flyckt RL; Liu J; Frasure H; Wekselman K; Buch A; Kingsberg SA
Menopause; 2009; 16(4):680-8. PubMed ID: 19325500
[TBL] [Abstract][Full Text] [Related]
37. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
38. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.
Warnock JK; Bundren JC; Morris DW
Psychopharmacol Bull; 1997; 33(4):761-6. PubMed ID: 9493489
[TBL] [Abstract][Full Text] [Related]
39. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
40. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
